Yarington C T
Proc R Soc Med. 1977 Jul;70(7):456-9. doi: 10.1177/003591577707000703.
In summary, cavernous sinus thrombosis is still with us. Patients now survive the disease more often than not, and therapy and diagnosis are reasonably clear cut. An increasing array of antibiotic-resistant bacteria have been balanced by an increasing army of antibiotics. The controversy over anticoagulation has not changed since reviewed by Parsons (1967). Ancillary measures remain more of value in diagnosis than in therapy. It is a disease primarily diagnosed by physical signs and symptoms, which requires prompt treatment. In our modern age of computerization and laboratory-based medical care, cavernous sinus thrombosis demands the diagnostic skill of the clinician, whose prompt ministrations should usually yield a favourable result.
总之,海绵窦血栓形成仍然存在。现在患者大多能从这种疾病中存活下来,治疗和诊断也相当明确。越来越多的抗生素与越来越多的耐药菌相互抗衡。自帕森斯(1967年)回顾以来,关于抗凝治疗的争议一直没有改变。辅助措施在诊断中的价值仍大于治疗。这是一种主要通过体征和症状诊断的疾病,需要及时治疗。在我们这个计算机化和基于实验室的现代医疗时代,海绵窦血栓形成需要临床医生的诊断技能,其及时的治疗通常会产生良好的效果。